Preclinical

(Image: Getty/Tampatra)

Year begins with bang for AI drug development

By Ben Hargreaves

Alongside the first drug developed by AI entering clinical trials, there have been a number of other instances of the technology being used to aid the discovery of new treatments.

(Image: Getty/Ivanmollov)

The potential of blockchain for clinical trials

By Ben Hargreaves

Due to the imperative for secure communication between stakeholders organizing clinical trials, a recent report suggests that blockchain technology could be a ‘perfect’ solution.

(Image: Getty/Andy)

Funding for AI startups dries up

By Ben Hargreaves

The number of startup companies emerging and the funding that they received took a sharp downturn in 2019.

Outsourcing-Pharma roundup October ‘19

People on the Move: Outsourcing-Pharma roundup October ‘19

By Melissa Fassbender

This month’s people on the move includes a new therapeutic lead at Advanced Clinical, with plans to create a network of investigation sites, as well as CEOs at AIT Bioscience and Pharm-Olam, who discuss plans for moving forward.

(Image: Getty/kunertus)

Charles River signs on to Dementia Consortium

By Melissa Fassbender

Charles River Laboratories recently announced that Alzheimer’s Research UK selected the company to join the Dementia Consortium to help researchers progress projects to in vivo proof of concept.

Follow us

Product Innovations